Clinical Trials Directory

Trials / Completed

CompletedNCT04339881

NOsocomial Dissemination Risk of SARS-Cov2

Status
Completed
Phase
Study type
Observational
Enrollment
2,523 (actual)
Sponsor
Assistance Publique - Hôpitaux de Paris · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

To date, in France, in the context of the SARS Cov2 pandemic,both the number of affected subjects and the number of severe forms requiring hospital care are increasing. Several nosocomial transmission clusters have already been identified in hospitals (both pediatric and adult) but there is still limited data on the nosocomial spread of SARS-Cov2. This nosocomial transmission affects both patients and caregivers. It is important to understand the spread of the virus within the hospital. This will help to optimize procedures to prevent transmission to caregivers and hospitalizedpatients not infected with SARS Cov2, and more generally this will contribute to control the spread of SARS Cov2 in the community

Detailed description

It is an observational study without any risk. Every participating service will be investigated for 2 consecutive days . * At each staff rotation, an individualsensorwill be provided toall thestaff(caregivers, administrative, students etc…) to be worn duringtheirworking hours. Also a sensor will be placed at each patient's bedside. * In addition, epidemiological data relating to socio-demographic characteristics, profession, protective measures will be collectedfrom hospitalstaff. Also, some data from the 'entrepot des données de santé" regarding individual carepathways in the hospitalwill be extracted. * A map of the unit, specifying the location of each patient will be made.

Conditions

Timeline

Start date
2020-04-17
Primary completion
2020-07-10
Completion
2020-07-12
First posted
2020-04-09
Last updated
2020-11-23

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04339881. Inclusion in this directory is not an endorsement.